Tetra Discovery Partners
Clinical trials sponsored by Tetra Discovery Partners, explained in plain language.
-
Experimental drug aims to boost brain function in fragile x syndrome
Disease control CompletedThis study tests an experimental drug called BPN14770 (zatolmilast) in men aged 18 to 45 with Fragile X syndrome, a genetic condition that causes intellectual disability and behavioral challenges. The trial compares the drug against a placebo to see if it improves cognitive abili…
Phase: PHASE3 • Sponsor: Tetra Discovery Partners • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Experimental drug aims to boost thinking skills in teens with fragile x
Symptom relief CompletedThis study tested a drug called zatolmilast (BPN14770) in 163 male adolescents aged 9 to 18 with Fragile X syndrome. The trial had two parts: one to check how the drug moves through the body, and another where some teens got the drug and others got a placebo. Researchers measured…
Phase: PHASE2, PHASE3 • Sponsor: Tetra Discovery Partners • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC